Risk factor
Very high price volatility
Profitability factor
Favourable analyst view
About
Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. Its Phreesia Platform offers a suite of solutions to manage the patient intake process, as well as an integrated payments solution for processing of patient payments. The company deploys its platform in a range of...
Company Valuation
From both historical and forecast perspectives, the stock is overpriced compared to similar stocks. In particular, the stock is 'expensive' on EV/EBITDA, overvalued on P/
Target Price
The average target price of PHR is 29 and suggests 82% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to increase
Buy
Sell